FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20282211000001105: Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Apr 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68390201000001112 Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68390301000001115 Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Is a Azithromycin 200mg/5ml oral suspension 30 ml true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has AMP Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has excipient Aspartame false Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has specific active ingredient Azithromycin true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Azithromycin true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sandoz Ltd) 30 ml Has basis of strength substance Azithromycin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start